Participants needed for neurodegeneration study

McGill’s Dr. Jens Pruessner is leading a study to investigate signs of early cognitive changes and neurodegeneration in aging individuals. The long-term objective of this project is to facilitate the early identification of individuals at high risk of Alzheimer Disease.

McGill’s Dr. Jens Pruessner is leading a study that aims to investigate signs of early cognitive changes and neurodegeneration in aging individuals. The long-term objective of this project is to facilitate the early identification of individuals at high risk of Alzheimer Disease. Participants will be followed yearly for a period of 24 months and will go through yearly magnetic resonance imaging (MRI) scan and neuropsychological evaluation.

To complete the last phase of our recruitment, the team is seeking participation of healthy, right-handed men aged between 55-60 and 70-75 years, with no past or present history of neurological, psychological or severe medical conditions, and no contra-indication for MRI (pacemaker, aneurysm clip, heart/vascular clip, prosthetic valve, metal prosthesis, claustrophobia, metal fragments).

Procedure: Yearly involvement includes two sessions (for a total of five hours per year) at the Brain Imaging Centre of the Douglas Mental Health Institute and the McGill Centre for Studies in Aging (MSCA).

Participants will be compensated for their time and inconvenience.

Contact: Interested people should call 514-761-6131 ext. 3298 and leave a voicemail, or email aging.study.mcsa@gmail.com